Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short-term Investments (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Short-term Investments for 16 consecutive years, with $10.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments rose 70.16% year-over-year to $10.1 million, compared with a TTM value of $10.1 million through Sep 2025, up 70.16%, and an annual FY2024 reading of $5.9 million, up 204.3% over the prior year.
  • Short-term Investments was $10.1 million for Q3 2025 at Rockwell Medical, up from $5.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $14.6 million in Q3 2022 and bottomed at $2.0 million in Q4 2023.
  • Average Short-term Investments over 5 years is $7.3 million, with a median of $5.9 million recorded in 2023.
  • The sharpest move saw Short-term Investments tumbled 82.86% in 2023, then skyrocketed 204.3% in 2024.
  • Year by year, Short-term Investments stood at $9.2 million in 2021, then grew by 24.37% to $11.4 million in 2022, then crashed by 82.86% to $2.0 million in 2023, then surged by 204.3% to $5.9 million in 2024, then skyrocketed by 69.98% to $10.1 million in 2025.
  • Business Quant data shows Short-term Investments for RMTI at $10.1 million in Q3 2025, $5.9 million in Q2 2025, and $5.9 million in Q1 2025.